Lynne Sullivan - Nov 4, 2024 Form 4 Insider Report for Unity Biotechnology, Inc. (UBX)

Role
CFO & Head of Corp. Dev.
Signature
/s/ Alexander Nguyen, Attorney-in-Fact for Lynne Sullivan
Stock symbol
UBX
Transactions as of
Nov 4, 2024
Transactions value $
-$175
Form type
4
Date filed
11/6/2024, 04:10 PM
Previous filing
Aug 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UBX Common Stock, $0.0001 par value Sale -$175 -136 -0.24% $1.29 55.9K Nov 4, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading instruction to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
F2 Includes Restricted Stock Units which vest over time measured from the grant date.